Filing Details
- Accession Number:
- 0001179110-16-030454
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-05 16:52:41
- Reporting Period:
- 2016-10-03
- Filing Date:
- 2016-10-05
- Accepted Time:
- 2016-10-05 16:52:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 861838 | Idera Pharmaceuticals Inc. | IDRA | Biological Products, (No Disgnostic Substances) (2836) | 043072298 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1280044 | Maxine Gowen | C/O Idera Pharmaceuticals, Inc. 167 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-10-03 | 4,102 | $2.56 | 10,543 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This stock was issued to the reporting person pursuant to her election under the Issuer's director compensation program in lieu of cash.
Billionaire Hedge Funds
